Lp(a): Are Antithrombotic Therapies the Key to Event Reduction?
- PMID: 36175049
- DOI: 10.1016/j.jacc.2022.08.722
Lp(a): Are Antithrombotic Therapies the Key to Event Reduction?
Keywords: aspirin; cardiovascular disease; genetics; lipoprotein(a); primary prevention.
Conflict of interest statement
Funding Support and Author Disclosures The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Comment on
-
Aspirin for Primary Prevention of Cardiovascular Events in Relation to Lipoprotein(a) Genotypes.J Am Coll Cardiol. 2022 Oct 4;80(14):1287-1298. doi: 10.1016/j.jacc.2022.07.027. J Am Coll Cardiol. 2022. PMID: 36175048 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous